CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 
 
 


Heska Corp  (HSKA)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 
   Industry Biotechnology & Drugs
   Sector  Healthcare
 


Heska Corp

HSKA's Fundamental analysis



You need to upgrade your Flash Player



Looking into Heska growth rates, revenue grew by 7.84 % in I. Quarter 2018 from the same quarter a year ago. Ranking at No. 1922

Biotechnology & Drugs industry recorded growth of revenues by 3.22 %

Heska's net profit deacreased by -49.92 % in I. Quarter 2018 year on year, to $2 millions.

More on HSKA's Growth




Heska
current PE on trailing twelve month basis is above Biotechnology & Drugs industry average.

Heska realized cash outflow of $ -0.01per share in trailing twelve-month period.
Company
108.61
PE TTM   
Industry
0
PE TTM    
Company's Price to Sales ratio is at 6.23.
Biotechnology & Drugs industry's Price to Sales ratio is at 5.55.

Heska Price to Book Ratio is at 7.81 lower than Indusry Avg. of 789.39. and higher than S&P 500 Avg. of -0.02

More on HSKA's Valuation

 Market Capitalization (Millions $) 821
 Shares Outstanding (Millions) 8
 Employees -
 Revenues (TTM) (Millions $) 132
 Net Income (TTM) (Millions $) 7
 Cash Flow (TTM) (Millions $) -0
 Capital Exp. (TTM) (Millions $) -3
 Total Debt (Millions $) 6
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover Ratio (TTM) 9.09
 Tangible Book Value (Per Share $) 13.39

 Market Capitalization (Millions $) 821
 Shares Outstanding (Millions) 8
 Employees -
 Revenues (TTM) (Millions $) 132
 Net Income (TTM) (Millions $) 7
 Cash Flow (TTM) (Millions $) -0
 Capital Exp. (TTM) (Millions $) -3
You need to upgrade your Flash Player
 Total Debt (Millions $) 6
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 9.09
 Tangible Book Value (Per Share $) 13.39

Profitability

Heska faced margin deterioraten, primarily through cost pressure. Operating Margin fell in I. Quarter 2018 to 5.71 % from 21.37 % in IV. Quarter.

Heska net profit margin of 6.58 % is currently ranking no. 20 in Biotechnology & Drugs industry, ranking no. 119 in Healthcare sector and number 1725 in S&P 500.

More on HSKA's Key Ratios
You need to upgrade your Flash Player

You need to upgrade your Flash Player
  Ratio
   Capital Ratio (MRQ) 2.68
  Total Debt to Equity (MRQ) 0.06
  Tangible Leverage Ratio (MRQ) 0.32
  Asset Turnover Ratio (TTM) 0.98
  Inventory Turnover Ratio (TTM) 2.47


Heska faced margin deterioraten, primarily through cost pressure. Operating Margin fell in I. Quarter 2018 to 5.71 % from 21.37 % in IV. Quarter.

Heska net profit margin of 6.58 % is currently ranking no. 20 in Biotechnology & Drugs industry, ranking no. 119 in Healthcare sector and number 1725 in S&P 500.

More on HSKA's Key Ratios


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

HPTO's Profile

Stock Price

HPTO's Financials

Business Description

Fundamentals

Charts & Quotes

HPTO's News

Suppliers

HPTO's Competitors

Customers & Markets

Economic Indicators

HPTO's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071